Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

43,878 stories, page 577 of 732

Advanced search

🇺🇸Jul 8Researchclinicaltrials.govTier 1 · Trial registry

NCT04315948: Trial of Treatments for COVID-19 in Hospitalized Adults

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 8Researchclinicaltrials.govTier 1 · Trial registry

NCT04231760: The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 8Researchclinicaltrials.govTier 1 · Trial registry

NCT04015128: A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 8Researchclinicaltrials.govTier 1 · Trial registry

NCT03366116: 5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 8Researchclinicaltrials.govTier 1 · Trial registry

NCT03269669: Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 8Researchclinicaltrials.govTier 1 · Trial registry

NCT02432378: Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 8Researchclinicaltrials.govTier 1 · Trial registry

NCT02154022: Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 8Researchclinicaltrials.govTier 1 · Trial registry

NCT01582204: Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 8Researchclinicaltrials.govTier 1 · Trial registry

NCT01087333: Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Medipost starts US phase 3 trial of Cartistem to expand from Korea - CHOSUNBIZ

ChosunbizOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Medipost Administers First Patient in U.S. Phase 3 Trial of CARTISTEM for Knee Osteoarthritis

아시아경제Original source

🇺🇰Jul 8Regulatorygov.ukTier 1 · Regulatory source

10 Year Capital Plan to rebuild NHS and bring care closer to home

Government announces 10 Year Capital Plan to modernise NHS buildings, upgrade GP surgeries and bring...

UK Department of Health and Social CareOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

NextGen VC Podcast – Why the Future of Biotech Starts with the Brain

Wilson SonsiniOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

CMPS Stock Clocks Muted Gains But Analysts Back Psychedelic Drug’s Durability Ahead Of FDA Filing

TradingViewOriginal source

🌍Jul 8discoverynews.google.comTier 2 · Trade media

Podcast: Servier describes its M&A and manufacturing strategy amidst deal-making drive

Pharmaceutical TechnologyOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

June 6, 2026: Judge blocks Colorado price cap on Enbrel

Partnership for Safe MedicinesOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Panel reviews food adulteration cases

Brighter KashmirOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

First-in-Class Drug Approved for IgA Nephropathy

MedPage TodayOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Industry groups press FDA for transparency, next steps for CNPV program

RAPSOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Assembly panel reviews food adulteration cases, seeks stricter enforcement

thekashmirimages.comOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Obesity biotech Kalohexis confidentially files to go public in US

ReutersOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

CoRegen clears FDA hurdle to start clinical trials for cancer therapy this fall

The Business JournalsOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

The Changing Reality of Pharmaceutical Commercialization | PharmExec

Pharmaceutical ExecutiveOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

This Space-Bound Biotech Startup Thinks It Can Cure Cognitive Decline—and It Just Launched a Historic Experiment

inc.comOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Bedford approves tax incentive to bring 300-plus pharmaceutical jobs to city

Cleveland.comOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

CoSE Dean Carmen Domingo honored for fostering next generation of biotech talent

San Francisco State UniversityOriginal source

🇺🇸Jul 8Industrycryoport.comTier 1 · Company source

Expand Trial Footprints Without Expanding Cryopreservation Risk

CryoportOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

This Biotech Stock Is Soaring 99% After Vertex Agrees to Takeover Deal

Barron'sOriginal source

🇺🇸Jul 8Researchorbimed.comTier 2 · Direct publisher

Vertex to Acquire Crinetics Pharmaceuticals

OrbiMedOriginal source

🇺🇸Jul 8Researchorbimed.comTier 2 · Direct publisher

The Oncology Institute Completes Strategic Refinancing with OrbiMed

OrbiMedOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Biotech and Biomed Engineering Grad and Certificate Programs to Debut at Auburn

Genetic Engineering and Biotechnology NewsOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Axsome Therapeutics doses first pediatric patient in Phase 3 ADHD study

grafa.comOriginal source

🇺🇸Jul 8Industrycryoport.comTier 1 · Company source

When Local Variation Becomes Global Risk in Phase III

CryoportOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

DEA Scientist Testifies Against DEA's Own Rescheduling Posture In Court

Newswire.comOriginal source

🇺🇸Jul 8Industrycryoport.comTier 1 · Company source

“Regulatory Readiness is Built Early” and Other Lessons for CGT Developers

CryoportOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Online GLP-1 Prescribing Lacks Adequate Safety, Oversight

Drug TopicsOriginal source

🇺🇸Jul 8Industrycryoport.comTier 1 · Company source

Cryoport Systems Wins Best Cell & Gene Therapy Supplier Award for Cold Chain Logistics at APCGTEA 2026

CryoportOriginal source

🌍Jul 8discoverynews.google.comTier 2 · Trade media

Merck KGaA-backed Cyllene Therapeutics secures €33m for gene therapy pipeline

Pharmaceutical TechnologyOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

SLS Stock: SELLAS Investors Look For More After 542% Surge

CMC MarketsOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”

Yahoo FinanceOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Jim Cramer Calls Biotech "The Hottest Group in the Market" as He Predicts "Deals Are Going to Be Flooding the Market"

24/7 Wall St.Original source

🇺🇸Jul 8Industrycryoport.comTier 1 · Company source

Scaling Animal Health Programs Shouldn’t Mean Requalifying Your Supply Chain

CryoportOriginal source

🌍Jul 8discoverynews.google.comTier 2 · Trade media

FDA approves Vera’s dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka

Fierce PharmaOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Study Identifies “Tiered Manufacturing” Across Global Pharmaceutical Markets as Potential Determinant of Health

publichealth.jhu.eduOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

FDA Advisory Panel to Assess Peptide Bulk Drug Substances from Obesity to Opioid

BenzingaOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

This Small-Cap Biotech Is Turning Heads on Wall Street

TheStreet ProOriginal source

🌍Jul 8discoverynews.google.comTier 2 · Trade media

Kailera says obesity pill succeeds in late-stage trial in China

BioPharma DiveOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

FDA’s regulatory outlook

PoliticoOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Biotech Supply Chain Market Size, Share | Growth Report [2034]

Fortune Business InsightsOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Novartis to acquire ADC biotech Myricx Bio for $1.5bn

Manufacturing ChemistOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

VERAXA Biotech (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5B ADC Acquisition

The Globe and MailOriginal source

🇺🇸Jul 7CROveristat.comTier 2 · Direct publisher

Monthly FDA Guidance and Regulatory News Review - June 2026

VeristatOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

AstraZeneca developing PP blister packaging for future drugs

Plastics NewsOriginal source

🇪🇺Jul 7Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: ENgineered CArtilage from Nose for the Treatment of Osteoarthritis (ENCANTO)

CORDISOriginal source

🌍Jul 7discoverynews.google.comTier 2 · Trade media

Compass says depression drug has long-lasting benefits

STATOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Peptide exceptionalism is a dangerous FDA loophole. Demand evidence, not hype

Washington ExaminerOriginal source

🌍Jul 7discoverynews.google.comTier 2 · Trade media

Bristol lays out KRAS med Krazati's stumble in confirmatory colorectal cancer trial

Fierce PharmaOriginal source

🌍Jul 7discoverynews.google.comTier 2 · Trade media

Boehringer bags PVT’s viral vector platform for cancer vaccine R&D

Fierce BiotechOriginal source

🌍Jul 7discoverynews.google.comTier 2 · Trade media

As US lawmakers increase scrutiny of Chinese trials, industry fears ‘huge distraction and expense’

Fierce BiotechOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

SBIO: Biotech Breakthrough Opportunities Screened For Cash Burn (NYSEARCA:SBIO)

Seeking AlphaOriginal source